Efficacy and Safety of SCRT Versus TNT in Older Patients With Locally Advanced Rectal Cancer
Status:
RECRUITING
Trial end date:
2033-12-01
Target enrollment:
Participant gender:
Summary
The SHAPERS study is a multicentre, open-label, randomised, pragmatic clinical trial, comparing standard-of-care neoadjuvant treatment options for older (i.e., ≥70 years) subjects with high-risk stage II and stage III rectal cancer.